Molecular models of tryptophan synthase from Mycobacterium tuberculosis complexed with inhibitors
- 235 Downloads
The development of new therapies against infectious diseases is vital in developing countries. Among infectious diseases, tuberculosis is considered the leading cause of death. A target for development of new drugs is the tryptophan pathway. The last enzyme of this pathway, tryptophan synthase (TRPS), is responsible for conversion of the indole 3-glycerol phosphate into indol and the condensation of this molecule with serine-producting tryptophan. The present work describes the molecular models of TRPS from Mycobacterium tuberculosis (MtTRPS) complexed with six inhibitors, the indole 3-propanol phosphate and five arylthioalkyl-phosphonated analogs of substrate of the α-subunit. The molecular models of MtTRPS present good stereochemistry, and the binding of the inhibitors is favorable. Thus, the generated models can be used in the design of more specific drugs against tuberculosis and other infectious diseases.
Index EntriesTryptophan synthase Mycobacterium tuberculosis molecular modeling drug design structural bioinformatics
Unable to display preview. Download preview PDF.
- 2.World Health Organization. Global Tuberculosis Control. WHO Report 2001. Geneva, Switzerland, WHO/CDS/TB/2001.287Google Scholar
- 6.Daves, G. M., Barrett-Bee, K. J. Jude, D. A., et al. (1994) (6S)-6-Fluoroshikimic acid, an antibacterial agent acting on the aromatic biosynthetic pathway. Antimicrob. Agents Chemother. 38, 403–406.Google Scholar
- 16.Brünger, A. T. (1992) X-PLOR version 3.1: a system for crystallography and NMR. Yale University Press, New Haven, CT.Google Scholar
- 20.Hyde, C. C., Ahmed, S. A., Padlan, E. A., Miles, E. W., and Davies, D. R. (1988) Three-dimensional structure of the tryptophan synthase α2β2 multienzyme complex from Salmonella typhimurium. J. Biol. Chem. 263, 17,857–17,871.Google Scholar
- 23.De Azevedo, W. F., Jr., Mueller-Dieckmann, H. J., Schulze-Gahmen, U., Worland, P. J., Sausville, E., and Kim, S. H. (1996) Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc. Natl. Acad. Sci. U.S.A. 93, 2735–2740.PubMedCrossRefGoogle Scholar